{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:47:05Z","timestamp":1790437625727,"version":"4.1.0"},"reference-count":17,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2020,2,1]]},"DOI":"10.1001\/jamaophthalmol.2019.5071","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T16:32:15Z","timestamp":1576773135000},"page":"128","source":"Crossref","is-referenced-by-count":17,"title":["Association of Messenger RNA Level With Phenotype in Patients With Choroideremia"],"prefix":"10.1001","volume":"138","author":[{"given":"Lewis E.","family":"Fry","sequence":"first","affiliation":[{"name":"Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"},{"name":"Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"},{"name":"NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Patr\u00edcio","sequence":"additional","affiliation":[{"name":"Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"},{"name":"Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"},{"name":"NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Williams","sequence":"additional","affiliation":[{"name":"Oxford Medical Genetics Laboratories, The Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Aylward","sequence":"additional","affiliation":[{"name":"Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"},{"name":"Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"},{"name":"NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harriet","family":"Hewitt","sequence":"additional","affiliation":[{"name":"Oxford Medical Genetics Laboratories, The Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Clouston","sequence":"additional","affiliation":[{"name":"Oxford Medical Genetics Laboratories, The Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanmin","family":"Xue","sequence":"additional","affiliation":[{"name":"Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"},{"name":"Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"},{"name":"NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alun R.","family":"Barnard","sequence":"additional","affiliation":[{"name":"Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"},{"name":"Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"},{"name":"Oxford Medical Genetics Laboratories, The Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert E.","family":"MacLaren","sequence":"additional","affiliation":[{"name":"Nuffield Laboratory of Ophthalmology, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom"},{"name":"Oxford Eye Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom"},{"name":"NIHR Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"eoi190085r1","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/0092-8674(93)90639-8","article-title":"cDNA cloning of component A of Rab geranylgeranyl transferase and demonstration of its role as a Rab escort protein.","volume":"73","author":"Andres","year":"1993","journal-title":"Cell"},{"issue":"7","key":"eoi190085r2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1080\/14712598.2018.1484448","article-title":"Choroideremia: molecular mechanisms and development of AAV gene therapy.","volume":"18","author":"Patr\u00edcio","year":"2018","journal-title":"Expert Opin Biol Ther"},{"issue":"10","key":"eoi190085r3","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1038\/s41591-018-0185-5","article-title":"Beneficial effects on vision in patients undergoing retinal gene therapy for choroideremia.","volume":"24","author":"Xue","year":"2018","journal-title":"Nat Med"},{"issue":"6294","key":"eoi190085r4","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/347674a0","article-title":"Cloning of a gene that is rearranged in patients with choroideraemia.","volume":"347","author":"Cremers","year":"1990","journal-title":"Nature"},{"issue":"3","key":"eoi190085r5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mgg3.2016.4.issue-3","article-title":"Analysis of a large choroideremia dataset does not suggest a preference for inclusion of certain genotypes in future trials of gene therapy.","volume":"4","author":"Freund","year":"2016","journal-title":"Mol Genet Genomic Med"},{"issue":"14","key":"eoi190085r6","doi-asserted-by":"publisher","first-page":"6033","DOI":"10.1167\/iovs.16-20230","article-title":"The spectrum of CHM gene mutations in choroideremia and their relationship to clinical phenotype.","volume":"57","author":"Simunovic","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"eoi190085r7","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1016\/j.ophtha.2018.02.004","article-title":"Retinal degeneration in choroideremia follows an exponential decay function.","volume":"125","author":"Aylward","year":"2018","journal-title":"Ophthalmology"},{"issue":"12","key":"eoi190085r8","doi-asserted-by":"publisher","first-page":"5575","DOI":"10.1167\/iovs.17-22486","article-title":"Characterizing the natural history of visual function in choroideremia using microperimetry and multimodal retinal imaging.","volume":"58","author":"Jolly","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"eoi190085r9","doi-asserted-by":"publisher","first-page":"282","DOI":"10.12688\/f1000research","article-title":"Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.","volume":"3","author":"Caminsky","year":"2014","journal-title":"F1000Res"},{"issue":"8","key":"eoi190085r10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.ejmg.2013.06.003","article-title":"A clinical molecular genetic service for United Kingdom families with choroideraemia.","volume":"56","author":"Ramsden","year":"2013","journal-title":"Eur J Med Genet"},{"key":"eoi190085r11","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.omtm.2018.03.009","article-title":"The biological activity of AAV vectors for choroideremia gene therapy can be measured by in vitro prenylation of RAB6A.","volume":"9","author":"Patr\u00edcio","year":"2018","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"11","key":"eoi190085r12","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1093\/hmg\/ddz028","article-title":"Nonsense-mediated mRNA decay efficiency varies in choroideremia providing a target to boost small molecule therapeutics.","volume":"28","author":"Sarkar","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"5","key":"eoi190085r13","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1002\/humu.v32.5","article-title":"LOVD v.2.0: the next generation in gene variant databases.","volume":"32","author":"Fokkema","year":"2011","journal-title":"Hum Mutat"},{"issue":"9","key":"eoi190085r14","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/humu.v30:9","article-title":"Sequence contexts that determine the pathogenicity of base substitutions at position +3 of donor splice-sites.","volume":"30","author":"Le Gu\u00e9dard-M\u00e9reuze","year":"2009","journal-title":"Hum Mutat"},{"issue":"7","key":"eoi190085r15","first-page":"726","article-title":"Altered rep-1 expression due to substitution at position +3 of the IVS13 splice-donor site of the choroideremia (CHM) gene.","volume":"17","author":"Beaufr\u00e8re","year":"1998","journal-title":"Curr Eye Res"},{"issue":"7","key":"eoi190085r16","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00109-013-1006-4","article-title":"Functional expression of Rab escort protein 1 following AAV2-mediated gene delivery in the retina of choroideremia mice and human cells ex vivo.","volume":"91","author":"Tolmachova","year":"2013","journal-title":"J Mol Med (Berl)"},{"issue":"2","key":"eoi190085r17","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1172\/JCI26617","article-title":"Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia.","volume":"116","author":"Tolmachova","year":"2006","journal-title":"J Clin Invest"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2757268\/jamaophthalmology_fry_2019_oi_190085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T16:01:16Z","timestamp":1581609676000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2757268"}},"subtitle":["Potential Implications for Gene Therapy Dose"],"short-title":[],"issued":{"date-parts":[[2020,2,1]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2019.5071","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2,1]]}}}